Trial matching services
Several Alzheimer associations have developed initiatives where you can register your interest in participating in trials and be matched with studies that are recruiting participants.
UK: Join Dementia Research – Service that enables you to register your interest and be matched with suitable research studies.
USA: Alzheimer’s Association TrialMatch – TrialMatch is a free, easy-to-use clinical studies matching service that connects individuals with Alzheimer’s, caregivers, healthy volunteers and physicians with current studies.
Australia: StepUp for Dementia Research – StepUp for Dementia Research is a research participation and engagement service, a “one-stop shop” that connects individuals – both with and without dementia – with researchers conducting studies into dementia prevention, diagnosis, treatment, care and cure.
Directories that you can search for trials that are recruiting.
WHO International Clinical Trials Registry Platform (ICTRP) – World Health Organization database containing the information about trials from multiple registries internationally.
European Council Clinical Trial Registry – Allows you to search for protocol and results information on interventional clinical trials that are conducted in the European Union (EU) and the European Economic Area (EEA).
Canada: Consortium of Canadian Centres for Clinical Cognitive Research (C5R) – Directory of Alzheimer’s and dementia studies taking place at several centres across Canada.
ClinicalTrials.gov – Provides a listing of trials being conducted around the world (site based in the US).
Alzheimer’s Clinical Trial Consortium (ACTC) established in 2017 is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias in the US, by supporting enhanced infrastructure for trials at 35 sites and a coordinating centre.
Alzheimer’s Prevention Registry – Banner Alzheimer’s Institute created and leads the Alzheimer’s Prevention Registry in collaboration with partnering organizations as part of its mission to end Alzheimer’s disease without losing another generation.